Disentangling the interactions between nasopharyngeal and gut microbiome and their involvement in the modulation of COVID-19 infection
暂无分享,去创建一个
M. Mor | F. Turroni | M. Ventura | A. Chetta | A. Nouvenne | T. Meschi | Leonardo Mancabelli | C. Milani | G. Lugli | Federico Fontana | Giulia Alessandri | Alice Viappiani | A. Ticinesi | O. Bussolati | Chiara Tarracchini | F. Vacondio | Tecla Ciociola | Giuseppe Taurino | Federica Vacondio | Massimiliano Bianchi | Alfredo Antonio Chetta | Marco Mor | G. Alessandri | L. Mancabelli | C. Tarracchini | F. Fontana | G. Taurino | M. Bianchi
[1] E. Mehraeen,et al. Gut microbiota and COVID‐19: A systematic review , 2023, Health science reports.
[2] S. Candel,et al. The nasopharyngeal microbiome in COVID-19 , 2023, Emerging microbes & infections.
[3] H. Xiang,et al. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential , 2022, World journal of gastroenterology.
[4] A. Buzoianu,et al. Gastrointestinal microbiota: A predictor of COVID-19 severity? , 2022, World journal of gastroenterology.
[5] Upendra K. Kar,et al. Lipidomic signatures align with inflammatory patterns and outcomes in critical illness , 2022, Nature communications.
[6] C. Trautwein,et al. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease , 2022, Frontiers in Cellular and Infection Microbiology.
[7] M. Joshi,et al. Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals , 2022, Microbial Pathogenesis.
[8] F. Turroni,et al. Untangling the link between the human gut microbiota composition and the severity of the symptoms of the COVID‐19 infection , 2022, Environmental microbiology.
[9] T. Miyoshi‐Akiyama,et al. Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications , 2022, Gastroenterology.
[10] A. Manges,et al. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity , 2022, medRxiv.
[11] D. Raoult,et al. Profile of the Nasopharyngeal Microbiota Affecting the Clinical Course in COVID-19 Patients , 2022, Frontiers in Microbiology.
[12] A. Weisz,et al. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy , 2022, Microbial Pathogenesis.
[13] E. Gratacós,et al. Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection , 2022, Scientific Reports.
[14] Yunfeng Yang,et al. SARS‐CoV‐2 triggered oxidative stress and abnormal energy metabolism in gut microbiota , 2022, MedComm.
[15] R. Vernal,et al. Oral-Gut-Brain Axis in Experimental Models of Periodontitis: Associating Gut Dysbiosis With Neurodegenerative Diseases , 2021, Frontiers in Aging.
[16] J. Buer,et al. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19 , 2021, Frontiers in Cellular and Infection Microbiology.
[17] M. Cominetti,et al. Phenylalanine and COVID-19: Tracking disease severity markers , 2021, International Immunopharmacology.
[18] Wen-Chi Su,et al. Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection , 2021, Viruses.
[19] F. Turroni,et al. METAnnotatorX2: a Comprehensive Tool for Deep and Shallow Metagenomic Data Set Analyses , 2021, mSystems.
[20] M. Shi,et al. Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19 , 2021, Synthetic and Systems Biotechnology.
[21] R. Boorstein,et al. Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights , 2021, medRxiv.
[22] Kang Zhang,et al. COVID-19 in early 2021: current status and looking forward , 2021, Signal Transduction and Targeted Therapy.
[23] Tao Zhang,et al. Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults , 2021, Communications biology.
[24] Jia Li,et al. Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19. , 2021, Annals of palliative medicine.
[25] S. Bernasconi,et al. Amoxicillin-Clavulanic Acid Resistance in the Genus Bifidobacterium , 2021, Applied and Environmental Microbiology.
[26] Timothy L. Tickle,et al. Multivariable association discovery in population-scale meta-omics studies , 2021, bioRxiv.
[27] K. Chow,et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 , 2021, Gut.
[28] Upendra K. Kar,et al. Lipidomic Signatures Align with Inflammatory Patterns and Outcomes in Critical Illness , 2021, Nature Communications.
[29] M. López-Pérez,et al. Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19 , 2020, bioRxiv.
[30] D. Crossman,et al. Strain Tracking to Identify Individualized Patterns of Microbial Strain Stability in the Developing Infant Gut Ecosystem , 2020, Frontiers in Pediatrics.
[31] J. Baizabal-Carvallo. Gut microbiota: a potential therapeutic target for Parkinson’s disease , 2020, Neural regeneration research.
[32] W. Giannobile,et al. The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis , 2020, Cell.
[33] Gek Huey Chua,et al. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis , 2020, Cell Metabolism.
[34] Lanjuan Li,et al. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] S. Ng,et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization , 2020, Gastroenterology.
[36] Huanhuan Gao,et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.
[37] Rebecca L. Moore,et al. Tracing mother-infant transmission of bacteriophages by means of a novel analytical tool for shotgun metagenomic datasets: METAnnotatorX , 2018, Microbiome.
[38] Emmanuel Paradis,et al. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R , 2018, Bioinform..
[39] T. Spector,et al. Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.
[40] W. D. de Vos,et al. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota , 2017, Microbiology and Molecular Biology Reviews.
[41] Lynn Vanhaecke,et al. Holistic Lipidomics of the Human Gut Phenotype Using Validated Ultra-High-Performance Liquid Chromatography Coupled to Hybrid Orbitrap Mass Spectrometry. , 2017, Analytical chemistry.
[42] Christopher Wilks,et al. Scaling read aligners to hundreds of threads on general-purpose processors , 2017, bioRxiv.
[43] G. Poli,et al. Lipid Oxidation Products in the Pathogenesis of Inflammation-related Gut Diseases. , 2017, Current medicinal chemistry.
[44] Suzanne M. Paley,et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases , 2015, Nucleic Acids Res..
[45] Ying Chen,et al. High speed BLASTN: an accelerated MegaBLAST search tool , 2015, Nucleic acids research.
[46] W. Rizzo. Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function. , 2014, Biochimica et biophysica acta.
[47] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[48] Yongan Zhao,et al. RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data , 2011, Bioinform..
[49] Haixu Tang,et al. RAPSearch: a fast protein similarity search tool for short reads , 2011, BMC Bioinformatics.
[50] L. Huc,et al. Chemistry and biochemistry of lipid peroxidation products , 2010, Free radical research.
[51] B. Fauconneau,et al. Plasmalogen degradation by oxidative stress: production and disappearance of specific fatty aldehydes and fatty alpha-hydroxyaldehydes. , 2001, Free radical biology & medicine.
[52] Y. Benjamini,et al. Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.
[53] R. Zoeller,et al. Isolation of Animal Cell Mutants Defective in Long-chain Fatty Aldehyde Dehydrogenase* , 1997, The Journal of Biological Chemistry.
[54] Haixu Tang,et al. RAPSearch 2 : a fast and memory-efficient protein similarity search tool for next-generation sequencing data , 2011 .
[55] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.